At myTomorrows, we facilitate access to pre-approval medicines and provide information about treatment options to create better healthcare. myTomorrows provides physicians and their patients with unmet medical needs access to not-yet-licensed medicines that have demonstrated safety and early efficacy but remain in clinical development or are otherwise inaccessible. To make these treatments available proactively, myTomorrows facilitates Early Access Programs (EAPs) through a patient-centric global platform.
Working together with companies to help develop their strategies for Early Access, myTomorrows creates and executes these programs through a global team, ensuring physicians are supported throughout the program. Additionally, myTomorrows collaborates with companies to collect Real World Evidence in support of their novel medicine.